VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ACIU
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ACIUAC Immune S.A.
$2.23$227M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksACIUQuarterly Financials

AC Immune S.A. (ACIU) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

AC Immune S.A. (ACIU) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

ACIU Income Statement

Quarterly statement

ACIU Income Statement

AC Immune S.A. (ACIU) annual income statement — 13-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue3.24M15.11M1.12M338K939K1.31M990K1.14M25.48M687K014.8M0001K3.93M000
Revenue Growth %245.47%1057.2%13.03%-70.27%-96.32%90.1%--92.32%-----100%-------100%
Cost of Goods Sold00000000000000015.14M14.38M000
COGS % of Revenue---------------1513600%365.66%---
Gross Profit3.24M15.11M1.12M338K939K1.31M990K1.14M25.48M687K014.8M000-15.13M-10.45M000
Gross Margin %100%100%100%100%100%100%100%100%100%100%-100%----1513500%-265.66%---
Gross Profit Growth %245.47%1057.2%13.03%-70.27%-96.32%90.1%--92.32%---197.79%100%------100%
Operating Expenses13.04M13.92M15.91M14.74M17.11M20.69M20.36M19.75M18.22M21.65M20.07M18.34M15.47M17.05M17.57M3.56M3.01M19.86M18.83M22.79M
OpEx % of Revenue402.13%92.11%1421.54%4362.13%1821.62%1584.53%2056.57%1737.47%71.48%3151.09%-123.92%---356200%76.56%---
Selling, General & Admin3.52M3.54M4.17M-254K3.57M3.9M4.44M-1.84M3.75M4.55M4.97M-676K3.46M3.68M4.11M3.96M3.27M4.37M4.17M-4.11M
SG&A % of Revenue108.57%23.42%373.01%-75.15%379.87%298.32%448.79%-161.92%14.73%662.45%--4.57%---396100%83.22%---
Research & Development9.85M10.48M11.74M10.54M13.07M16.83M15.92M15.79M14.48M17.14M15.16M14.64M12.41M13.68M13.87M15.14M14.38M15.69M15.12M20.12M
R&D % of Revenue303.73%69.32%1049.51%3119.02%1392.01%1288.36%1607.68%1388.3%56.83%2494.61%-98.94%---1513600%365.66%---
Other Operating Expenses-330K-96K-11K1000K467K-28K1K1000K-19K-41K-68K1000K-406K-317K-408K-1000K-1000K-207K-459K1000K
Operating Income-9.8M1.19M-14.79M-14.41M-16.17M-19.39M-19.37M-18.62M7.27M-20.96M-20.07M-3.54M-15.47M-17.05M-17.57M-18.7M-13.46M-19.86M-18.83M-22.79M
Operating Margin %-302.13%7.89%-1321.54%-4262.13%-1721.62%-1484.53%-1956.57%-1637.47%28.52%-3051.09%--23.92%----1869700%-342.22%---
Operating Income Growth %39.37%106.15%23.66%22.62%-322.4%7.5%3.48%-425.78%147%-22.97%-14.21%81.06%-14.88%14.16%6.69%17.95%33.62%-6.26%-9.15%-17.07%
EBITDA-8.69M1.94M-14.74M-13.76M-15.55M-18.77M-18.76M-18.09M7.8M-20.41M-19.51M-2.99M-14.92M-16.5M-17M-18.23M-13.03M-19.28M-18.23M-22.16M
EBITDA Margin %-267.91%12.8%-1316.89%-4069.82%-1656.34%-1436.83%-1894.75%-1590.94%30.6%-2971.32%--20.17%----1823500%-331.09%---
EBITDA Growth %44.12%110.31%21.44%23.95%-299.45%8.07%3.86%-505.79%152.28%-23.68%-14.77%83.62%-14.53%14.41%6.74%17.71%33.7%-6.57%-9.14%-16.28%
D&A (Non-Cash Add-back)000650.02K613K623K612K529K529K548K556K555K549K541K570K462K438K575K600K628K
EBIT-8.69M1.94M-14.74M-14.33M-15.86M-21.14M-18.98M-15.76M5.54M-22.73M-17.83M-4.72M-15.11M-16.8M-17.41M-18.75M-13.44M-19.51M-18.69M-21.1M
Net Interest Income221K110K163K308.64K320K408K633K859K906K705K593K265K259K232K112K59K-66K-126K-154K1.89M
Interest Income280K171K228K350.32K320K458K687K889K939K739K629K291K285K259K209K59K11K002.06M
Interest Expense59K61K65K41.68K050K54K30K33K34K36K26K26K27K97K077K126K154K173K
Other Income/Expense1.05M681K-13K33K308K-1.8M341K2.82M-1.77M-1.8M2.21M-1.2M326K216K61K-50K-49K219K-14K1.51M
Pretax Income-8.75M1.87M-14.8M-14.37M-15.86M-21.19M-19.03M-15.79M5.5M-22.76M-17.86M-4.74M-15.14M-16.83M-17.51M-18.75M-13.51M-19.64M-18.84M-21.27M
Pretax Margin %-269.73%12.4%-1322.7%-4252.37%-1688.82%-1622.43%-1922.12%-1389.09%21.59%-3312.95%--32.05%----1874700%-343.47%---
Income Tax00000003K0001K3K3K3K2K4K3K4K3K
Effective Tax Rate %0%0%0%0%0%0%0%-0.02%0%0%0%-0.02%-0.02%-0.02%-0.02%-0.01%-0.03%-0.02%-0.02%-0.01%
Net Income-8.75M1.87M-14.8M-14.37M-15.86M-21.19M-19.03M-15.8M5.5M-22.76M-17.86M-4.74M-15.14M-16.83M-17.51M-18.75M-13.52M-19.64M-18.85M-21.28M
Net Margin %-269.73%12.4%-1322.7%-4252.37%-1688.82%-1622.43%-1922.12%-1389.36%21.59%-3312.95%--32.05%----1874900%-343.57%---
Net Income Growth %44.82%108.84%22.22%9.01%-388.17%6.9%-6.53%-232.99%136.34%-35.21%-1.99%74.7%-12.04%14.31%7.08%11.88%15.09%-3.01%-12.63%-9.11%
Net Income (Continuing)-8.75M1.87M-14.8M-14.37M-15.86M-21.19M-19.03M-15.8M5.5M-22.76M-17.86M-4.74M-15.14M-16.83M-17.51M-18.75M-13.52M-19.64M-18.85M-21.28M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.130.02-0.15-0.14-0.16-0.21-0.19-0.150.05-0.23-0.18-0.06-0.18-0.20-0.21-0.22-0.16-0.25-0.24-0.27
EPS Growth %18.75%109.05%21.05%6.67%-420%8.7%-5.56%-165.96%127.78%-15%14.29%74.36%-12.5%20%12.5%18.52%27.27%3.85%-4.35%0%
EPS (Basic)-0.130.02-0.15-0.14-0.16-0.21-0.19-0.150.06-0.23-0.18-0.06-0.18-0.20-0.21-0.22-0.16-0.25-0.24-0.27
Diluted Shares Outstanding99.43M98.67M98.67M101.17M99.11M100.63M100.41M100.86M100.86M99.55M99.39M84.14M84.14M84.14M84.14M83.59M83.59M79.27M79.27M79.27M
Basic Shares Outstanding99.43M98.67M98.67M101.17M99.11M100.63M100.41M100.86M99.84M99.55M99.39M84.14M84.14M84.14M84.14M83.59M83.59M79.27M79.27M79.27M
Dividend Payout Ratio--------------------